
Details Emerge on Chinese-Version Huawei Enjoy 50 Pro Smartphone
A promotional poster for Huawei's new Enjoy 50 Pro smartphone was exposed on July 26, showing that the device will be officially released on July 29.
Showing 12 of 13045 posts
A promotional poster for Huawei's new Enjoy 50 Pro smartphone was exposed on July 26, showing that the device will be officially released on July 29.
At a summit today, Trip.com Group's Chairman and Co-founder James Liang outlined how he views the progression of international travel recovery.
The launch of Meituan's overseas app Keeta in Riyadh, the capital of Saudi Arabia, signifies further expansion into the Middle East market.
Beijing Benz, a joint venture between Mercedes-Benz and Chinese automaker BAIC Motor, filed a recall plan on October 28. The move expands a recall plan for certain EQA, EQB and EQC electric vehicle models released on February 18, 2022.
YKCCN.com (YKC), a new energy Internet of Things (IoT) service provider, announced on Monday that it has completed a B2 round of financing in which NIO Capital served as an investor.
“I regret not having entered into China’s market earlier. Now, I can hear vibrating sounds everywhere making me uncomfortable,” said Louis Yang, founder of Musi...
Media reports on August 12 stated that Zhang Lei, CEO of lantouzi.com, faces punishment by border control authorities, not Zhang Lei of Hillhouse Capital.
China far outnumbers the US in blockchain patents and leads the world, according to the latest blockchain patent list. Alibaba is the world’s leading enterprise...
JIDU, an intelligent electric vehicle company backed by Baidu and Geely, unveiled on Wednesday its first concept robocar, the ROBO-01.
Beijing-based consumer electronics giant Xiaomi recently issued a document announcing organizational adjustment.
SF Express Holding announced its wholly owned subsidiary Shenzhen SF Tyson Holdings had signed a cooperation agreement with the Hubei Provincial Government. SF ...
Talks between Chinese regulators and US pharmaceutical company Pfizer regarding the potential inclusion of Paxlovid, an orally administered COVID-19 medication, in the country's public health insurance scheme have broken down.